- American City Business Journals•10 hours ago
Earnings season for our Massachusetts biotech giants kicks off this week when Vertex Pharmaceuticals reports its third quarter financials on Tuesday evening, followed by Biogen on Wednesday morning. While probably just a fluke, it’s unusual for Vertex (VRTX) to be the first local biotech to give a quarterly update, as that honor usually goes to Biogen (BIIB). Vertex : To some extent, the financial news expected from the Boston-based company is already old news.
- Benzinga•17 hours ago
H.C. Wainwright & Co. downgraded shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) from Buy to a Neutral rating citing that fundamentals are not holding up. The firm also slashed its target ...
Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Day's Range||77.92 - 80.39|
|52wk Range||75.90 - 134.71|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-69.43|
|Avg Vol (3m)||1,414,667|
|Dividend & Yield||N/A (N/A)|